RxDoctor Payments Data

Lauren Larson, MD

Interventional Pain Medicine · Lexington, KYNPI 1316944192

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Merz North America, Inc. at 53.2% of the total. Reporting peaked in 2019 at $451 and has fallen 90.5% since, to $43 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in KY, where the typical reported total is $3,169.

$1,533in general payments, 2019–2025

Across 27 payments — averaging $56.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$815
  • Nevro Corp.$141
  • Abbott$133
  • Protega Pharmaceutials Inc$75
  • Medtronic$58
  • Scilex Pharmaceuticals Inc.$43
  • plus $268 from 11 others

What the payments were for

  • Speaking & faculty fees$131%
  • Food & beverage$1,52099%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,533 in reported general payments places this provider in the 30th percentile of 55 interventional pain medicine providers in Kentucky.

See all interventional pain medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$96,921
Medicare patients
213
Services billed
2,568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,582$37,951
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,870$35,163
Gabapentin2,249$24,957
Oxymorphone Hcl ErOxymorphone Hcl72$20,533
OxycontinOxycodone Hcl26$18,910
Oxycodone Hcl959$17,221
Fentanyl137$12,675
Morphine Sulfate ErMorphine Sulfate376$8,551
Pregabalin257$6,738
Methadone Hcl273$4,789
Hydrocodone-IbuprofenHydrocodone/Ibuprofen12$3,125
Lidocaine19$2,690
Tramadol Hcl ErTramadol Hcl32$2,494
Diclofenac Sodium41$1,678
Tizanidine Hcl115$707

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →